Smart for Life (SMFL) Competitors $0.03 +0.01 (+44.00%) As of 01/13/2025 12:57 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SMFL vs. BDRX, PRFX, PXMD, SRNE, TFFP, TCBP, NEXI, BLPH, SEEL, and TCONShould you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Biodexa Pharmaceuticals (BDRX), PainReform (PRFX), PaxMedica (PXMD), Sorrento Therapeutics (SRNE), TFF Pharmaceuticals (TFFP), TC Biopharm (TCBP), NexImmune (NEXI), Bellerophon Therapeutics (BLPH), Seelos Therapeutics (SEEL), and TRACON Pharmaceuticals (TCON). These companies are all part of the "pharmaceutical products" industry. Smart for Life vs. Biodexa Pharmaceuticals PainReform PaxMedica Sorrento Therapeutics TFF Pharmaceuticals TC Biopharm NexImmune Bellerophon Therapeutics Seelos Therapeutics TRACON Pharmaceuticals Smart for Life (NASDAQ:SMFL) and Biodexa Pharmaceuticals (NASDAQ:BDRX) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, valuation, analyst recommendations, media sentiment, dividends, profitability and risk. Do analysts rate SMFL or BDRX? Biodexa Pharmaceuticals has a consensus target price of $200.00, indicating a potential upside of 4,673.27%. Given Biodexa Pharmaceuticals' stronger consensus rating and higher possible upside, analysts clearly believe Biodexa Pharmaceuticals is more favorable than Smart for Life.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smart for Life 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biodexa Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better valuation & earnings, SMFL or BDRX? Biodexa Pharmaceuticals has lower revenue, but higher earnings than Smart for Life. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmart for Life$11.11M0.02-$22.68M-$1.12 thousand0.00Biodexa Pharmaceuticals$83K6.01-$7.66MN/AN/A Does the media favor SMFL or BDRX? In the previous week, Biodexa Pharmaceuticals had 3 more articles in the media than Smart for Life. MarketBeat recorded 3 mentions for Biodexa Pharmaceuticals and 0 mentions for Smart for Life. Biodexa Pharmaceuticals' average media sentiment score of 1.59 beat Smart for Life's score of 0.00 indicating that Biodexa Pharmaceuticals is being referred to more favorably in the news media. Company Overall Sentiment Smart for Life Neutral Biodexa Pharmaceuticals Very Positive Is SMFL or BDRX more profitable? Company Net Margins Return on Equity Return on Assets Smart for LifeN/A N/A N/A Biodexa Pharmaceuticals N/A N/A N/A Does the MarketBeat Community favor SMFL or BDRX? Smart for Life and Biodexa Pharmaceuticals both received 1 outperform votes by MarketBeat users. CompanyUnderperformOutperformSmart for LifeOutperform Votes1100.00% Underperform VotesNo VotesBiodexa PharmaceuticalsOutperform Votes1100.00% Underperform VotesNo Votes Which has more risk & volatility, SMFL or BDRX? Smart for Life has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500. Comparatively, Biodexa Pharmaceuticals has a beta of 1.46, meaning that its share price is 46% more volatile than the S&P 500. Do institutionals & insiders believe in SMFL or BDRX? 28.4% of Smart for Life shares are held by institutional investors. Comparatively, 17.5% of Biodexa Pharmaceuticals shares are held by institutional investors. 31.7% of Smart for Life shares are held by insiders. Comparatively, 0.3% of Biodexa Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. SummaryBiodexa Pharmaceuticals beats Smart for Life on 8 of the 11 factors compared between the two stocks. Get Smart for Life News Delivered to You Automatically Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMFL vs. The Competition Export to ExcelMetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$204,000.00$1.16B$5.24B$8.79BDividend YieldN/AN/A5.07%4.00%P/E Ratio0.0031.7586.2316.93Price / Sales0.026.281,082.87114.92Price / CashN/A10.5543.2137.77Price / Book0.001.885.054.89Net Income-$22.68M-$51.72M$122.23M$228.39M7 Day PerformanceN/A-5.65%-4.21%-3.72%1 Month PerformanceN/A-3.38%-0.34%0.03%1 Year PerformanceN/A-9.97%25.18%13.52% Smart for Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMFLSmart for LifeN/A$0.03+44.0%N/A-99.8%$204,000.00$11.11M0.00110BDRXBiodexa Pharmaceuticals3.0562 of 5 stars$4.45-1.1%$200.00+4,394.4%N/A$530,000.00$83,000.000.0021Short Interest ↓Positive NewsPRFXPainReform2.3552 of 5 stars$3.47+4.5%$8.00+130.5%-71.0%$503,000.00N/A-0.024Positive NewsPXMDPaxMedicaN/A$0.03-53.9%N/A-91.4%$340,000.00N/A0.002News CoverageGap DownHigh Trading VolumeSRNESorrento TherapeuticsN/A$0.00flatN/A-99.6%$331,000.00$60.32M0.00800Gap DownTFFPTFF Pharmaceuticals3.0249 of 5 stars$0.07flat$44.00+67,592.3%N/A$289,000.00$-70,983.00-0.0119TCBPTC Biopharm2.1341 of 5 stars$0.50-3.6%$3.00+495.9%-97.8%$266,000.00$4.76M0.0041Short Interest ↑Gap UpNEXINexImmuneN/A$0.11+12.9%N/A-99.0%$158,000.00N/A-0.016Gap UpBLPHBellerophon Therapeutics0.4704 of 5 stars$0.01-25.5%N/A-79.7%$147,000.00$5.64M-0.0120Analyst ForecastGap DownSEELSeelos TherapeuticsN/A$0.36+43.4%N/A-99.8%$133,000.00$2.20M0.0020Gap UpTCONTRACON Pharmaceuticals1.0604 of 5 stars$0.03-26.0%$60.00+186,235.4%-99.0%$110,000.00$12.05M0.0120Gap Down Related Companies and Tools Related Companies Biodexa Pharmaceuticals Competitors PainReform Competitors PaxMedica Competitors Sorrento Therapeutics Competitors TFF Pharmaceuticals Competitors TC Biopharm Competitors NexImmune Competitors Bellerophon Therapeutics Competitors Seelos Therapeutics Competitors TRACON Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SMFL) was last updated on 1/14/2025 by MarketBeat.com Staff From Our PartnersCharles Payne Wants You Prepared for 2025Charles Payne Wants You Prepared for 2025 There's no denying that market volatility, inflation, and recessi...Unstoppable Prosperity | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | Sponsored$24 trillion tech spotted at Mar-a-Lago?President Trump’s Secret Service was recently spotted using an odd new technology at his home in Mar-a-Lago…Centurion Publishing | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedThis secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | Sponsoredliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smart for Life, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smart for Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
